148 related articles for article (PubMed ID: 28038414)
1. Application of mesoscale simulation to explore the aggregate morphology of pH-sensitive nanoparticles used as the oral drug delivery carriers under different conditions.
Wang Y; Chen BZ; Liu YJ; Wu ZM; Guo XD
Colloids Surf B Biointerfaces; 2017 Mar; 151():280-286. PubMed ID: 28038414
[TBL] [Abstract][Full Text] [Related]
2. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
3. Solvent mediated microstructures and release behavior of insulin from pH-sensitive nanoparticles.
Wu ZM; Guo XD; Zhang LJ; Jiang W; Ling L; Qian Y; Chen Y
Colloids Surf B Biointerfaces; 2012 Jun; 94():206-12. PubMed ID: 22356870
[TBL] [Abstract][Full Text] [Related]
4. Poly(lactic-co-glycolic acid) as a particulate emulsifier.
Whitby CP; Lim LH; Eskandar NG; Simovic S; Prestidge CA
J Colloid Interface Sci; 2012 Jun; 375(1):142-7. PubMed ID: 22440727
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Composite Microcapsules for Oral Delivery of Insulin.
Sun S; Liang N; Gong X; An W; Kawashima Y; Cui F; Yan P
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036045
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine strategy for optimizing delivery to outer hair cells by surface-modified poly(lactic/glycolic acid) nanoparticles with hydrophilic molecules.
Wen X; Ding S; Cai H; Wang J; Wen L; Yang F; Chen G
Int J Nanomedicine; 2016; 11():5959-5969. PubMed ID: 27877041
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticles for peroral delivery: How important is pancreatic digestion and can we control it?
Mante A; Heider M; Zlomke C; Mäder K
Eur J Pharm Biopharm; 2016 Nov; 108():32-40. PubMed ID: 27553262
[TBL] [Abstract][Full Text] [Related]
9. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
[TBL] [Abstract][Full Text] [Related]
10. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
11. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.
Cui FD; Tao AJ; Cun DM; Zhang LQ; Shi K
J Pharm Sci; 2007 Feb; 96(2):421-7. PubMed ID: 17051590
[TBL] [Abstract][Full Text] [Related]
12. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases.
Ali H; Weigmann B; Neurath MF; Collnot EM; Windbergs M; Lehr CM
J Control Release; 2014 Jun; 183():167-77. PubMed ID: 24685705
[TBL] [Abstract][Full Text] [Related]
13. Calcium Stearate as an Effective Alternative to Poly(vinyl alcohol) in Poly-Lactic-co-Glycolic Acid Nanoparticles Synthesis.
Cella C; Gerges I; Milani P; Lenardi C; Argentiere S
Biomacromolecules; 2017 Feb; 18(2):452-460. PubMed ID: 28030952
[TBL] [Abstract][Full Text] [Related]
14. Comparative examination of adsorption of serum proteins on HSA- and PLGA-based nanoparticles using SDS-PAGE and LC-MS.
Gossmann R; Fahrländer E; Hummel M; Mulac D; Brockmeyer J; Langer K
Eur J Pharm Biopharm; 2015 Jun; 93():80-7. PubMed ID: 25813886
[TBL] [Abstract][Full Text] [Related]
15. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL
Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052
[TBL] [Abstract][Full Text] [Related]
16. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
17. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
Simon LC; Sabliov CM
Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927
[TBL] [Abstract][Full Text] [Related]
18. Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration.
Ru G; Han L; Qing J; Sheng J; Li R; Qiu M; Wang J
Drug Deliv; 2016 Nov; 23(9):3417-3423. PubMed ID: 27174642
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
20. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
